Loading
Latest filing published 06 Jul 2010 for Spectrum Pharmaceuticals INC, €30k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Dilip J. Mehta MD PhD is a declared insider at 2 companies; the most frequent names are Targanta Therapeutics Corp. and Spectrum Pharmaceuticals Inc. In total, 10 filings cover trades dated from 15 October 2007 to 6 July 2010.
No open-market sale appears; the market trades are 1 purchase worth €30k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2010 to date brings 1 purchase and no sales.
The latest filing, published on 6 July 2010, reports an open-market purchase of €30k in Spectrum Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations